GO:0006508 proteolysis: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006508 proteolysis is the biological process of hydrolyzing proteins into smaller polypeptides or amino acids by cleavage of peptide bonds.
• Proteolysis is a key post-translational modification that regulates proteoglycan function and extracellular matrix turnover.
• Dysregulated proteolysis contributes to cancer, intervertebral disc degeneration, and tumor microenvironment acidosis.
• Proteolysis-targeting chimeras (PROTACs) and nano-PROTACs are therapeutic strategies that hijack proteolysis to degrade disease-causing proteins.
• Hormone proteolysis generates bioactive fragments with distinct endocrine functions.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of proteolysis-related genes.
Description
Proteolysis (GO:0006508) is the enzymatic hydrolysis of proteins into smaller polypeptides and amino acids through cleavage of peptide bonds. This process is not merely a terminal degradation step; it is a highly regulated post-translational modification that controls protein abundance, activity, and function across all kingdoms of life. In reproduction, gene-modified organism studies have revealed essential roles for proteolysis in gamete interaction, implantation, and embryonic development. In the extracellular matrix, proteolysis of proteoglycans modulates cell signaling, tissue remodeling, and mechanical properties. The biomedical importance of proteolysis extends to cancer biology, where PROTACs and nano-PROTACs exploit the ubiquitin-proteasome system to degrade oncoproteins. In the tumor microenvironment, acidosis promotes proteolysis and drives invasive phenotypes. Intervertebral disc degeneration is characterized by excessive ECM proteolysis, making it a target for therapeutic intervention. Hormone proteolysis generates bioactive peptides with distinct endocrine roles, expanding the scope of proteolysis beyond simple catabolism. Researchers studying proteolysis need robust experimental models to identify causal genes, define cleavage specificity, and test therapeutic hypotheses.
proteolysis At A Glance
| GO ID | GO:0006508 |
|---|---|
| GO term | proteolysis |
| Ontology | biological_process |
| Synonym | ATP-dependent proteolysis; peptidolysis |
| Definition | The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. |
| Major function | Protein turnover, post-translational regulation, ECM remodeling, hormone processing, and immune defense. |
| Related diseases | Cancer, intervertebral disc degeneration, reproductive disorders, and metabolic/endocrine imbalances. |
| Therapeutic relevance | PROTACs and nano-PROTACs exploit proteolysis for targeted protein degradation. |
What Is GO:0006508?
According to the Gene Ontology, GO:0006508 proteolysis is defined as the hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. This biological process encompasses both ATP-dependent and ATP-independent mechanisms and is synonymous with peptidolysis. Proteolysis is carried out by proteases (peptidases) that recognize specific substrate sequences or structural features, and it can be tightly regulated by inhibitors, compartmentalization, and post-translational modifications.
Why Is proteolysis Important in Cell Biology?
Proteolysis is fundamental to cellular homeostasis because it controls the lifetime, abundance, and activity of essentially every protein. It enables rapid responses to environmental cues, removes damaged or misfolded proteins, and generates bioactive peptides from precursors. In disease, altered proteolysis contributes to cancer progression, tissue degeneration, and metabolic dysfunction, making proteases and proteolytic pathways attractive therapeutic targets.
• Regulates protein turnover and quality control.
• Controls extracellular matrix remodeling and proteoglycan function.
• Generates bioactive hormone fragments with endocrine roles.
• Supports reproduction, including gamete interaction and implantation.
• Drives tumor invasion and metastasis under acidic conditions.
• Enables targeted protein degradation via PROTACs and nano-PROTACs.
• Contributes to intervertebral disc degeneration through ECM breakdown.
• Provides safety considerations for drug development targeting proteolysis.
• Serves as a paradigm for post-translational regulation.
• Offers biomarkers and therapeutic targets across multiple diseases.
What Happens During proteolysis?
Substrate recognition and binding
In simple terms: The protease first finds and grabs the protein it needs to cut.
Proteases recognize substrates through specific sequence motifs, structural elements, or post-translational marks. In reproduction, gene-modified organism studies have identified proteases that bind to gamete surface proteins with high specificity. Proteoglycan proteolysis requires recognition of core protein regions or glycosaminoglycan chains. This step ensures selectivity and prevents unwanted degradation.
Peptide bond hydrolysis
In simple terms: The protease cuts the protein chain at a specific spot.
Catalysis occurs via nucleophilic attack on the carbonyl carbon of the peptide bond, often using a catalytic triad or metal ion. This hydrolysis generates smaller polypeptides or amino acids. The reaction can be ATP-dependent, as in proteasomal degradation, or ATP-independent, as in many matrix metalloproteinases.
Product release and downstream signaling
In simple terms: The cut pieces are released and can send signals or be further degraded.
Cleavage products can act as signaling molecules, such as hormone fragments generated by specific proteolysis. In the tumor microenvironment, acidosis promotes proteolysis that releases ECM-bound growth factors and enhances invasion. In intervertebral disc degeneration, proteolytic fragments contribute to inflammation and matrix breakdown.
Regulation by inhibitors and compartments
In simple terms: The cutting is controlled by inhibitors and by keeping proteases in specific places.
Endogenous inhibitors (e.g., TIMPs, serpins) and compartmentalization (lysosomes, proteasomes) restrict proteolysis to appropriate contexts. Dysregulation of these controls leads to pathological proteolysis in cancer and degeneration.
Integration with ubiquitin-proteasome system
In simple terms: Tagged proteins are sent to the proteasome for destruction.
The ubiquitin-proteasome system is a major ATP-dependent proteolytic pathway. PROTACs and nano-PROTACs hijack this system to degrade specific target proteins, including oncoproteins in breast cancer. Safety considerations for PROTACs include potential effects on normal proteolysis.
Key Genes Involved in GO:0006508 proteolysis
The following genes and proteins are central to proteolysis research, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MMP1 | Collagenase; ECM degradation | Intervertebral disc degeneration and cancer invasion |
| MMP2 | Gelatinase; ECM remodeling | Tumor microenvironment and disc degeneration |
| MMP9 | Gelatinase; ECM degradation | Cancer metastasis and inflammation |
| ADAMTS4 | Aggrecanase; proteoglycan cleavage | Intervertebral disc degeneration |
| ADAMTS5 | Aggrecanase; proteoglycan cleavage | Cartilage and disc degeneration |
| CTSK | Cathepsin K; collagen degradation | Bone and ECM remodeling |
| CTSL | Cathepsin L; lysosomal proteolysis | Cancer progression and hormone processing |
| PSMB5 | Proteasome subunit; ATP-dependent proteolysis | PROTAC mechanism and drug safety |
| PSMC4 | Proteasome ATPase; substrate unfolding | Proteolysis-targeting chimeras |
| CUL2 | E3 ubiquitin ligase; substrate recognition | PROTAC design and cancer therapy |
| VHL | E3 ligase component; hypoxia signaling | PROTAC targeting and cancer |
| CRBN | E3 ligase substrate receptor | PROTAC and nano-PROTAC development |
| ACE2 | Peptidase; hormone and viral processing | Reproduction and endocrine proteolysis |
| INS | Insulin precursor; proteolytic processing | Hormone proteolysis |
| PCSK1 | Prohormone convertase; peptide hormone maturation | Endocrine proteolysis |
| TIMP1 | MMP inhibitor; regulates proteolysis | ECM turnover and disc degeneration |
| TIMP2 | MMP inhibitor; regulates proteolysis | Cancer and tissue remodeling |
How Is proteolysis Regulated?
Proteolysis is regulated at multiple levels, including protease gene expression, zymogen activation, inhibitor binding, and compartmentalization. In the tumor microenvironment, acidosis enhances proteolytic activity and promotes invasion. Hormone proteolysis is controlled by prohormone convertases and can generate fragments with distinct bioactivities. The ubiquitin-proteasome system is regulated by E3 ligases and deubiquitinases, which are exploited by PROTACs. Safety perspectives highlight the need to understand systemic effects of modulating proteolysis.
proteolysis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MMP9 | Cancer metastasis and invasion | Knockout in cancer cell lines; overexpression in xenografts |
| ADAMTS5 | Intervertebral disc degeneration | Knockout mouse; point mutation in catalytic domain |
| PCSK1 | Endocrine disorders | Knock-in of patient mutations; overexpression in endocrine cells |
| CRBN | PROTAC sensitivity in cancer | Knockout for resistance; knock-in of tagged CRBN |
| ACE2 | Reproductive and cardiovascular biology | Knockout and knock-in models for hormone processing |
Cancer and the tumor microenvironment
Proteolysis drives cancer progression by degrading ECM barriers, releasing growth factors, and activating signaling pathways. Acidosis in the tumor microenvironment promotes proteolytic activity and invasion. PROTACs and nano-PROTACs represent therapeutic strategies that redirect proteolysis to degrade oncoproteins in breast cancer and other malignancies. Safety considerations for PROTACs include potential off-target proteolysis.
Intervertebral disc degeneration
Excessive proteolysis of the extracellular matrix, particularly by MMPs and ADAMTS proteases, contributes to intervertebral disc degeneration. Proteoglycan cleavage fragments can trigger inflammation and further matrix breakdown. Targeting proteolysis is a potential therapeutic approach for disc degeneration.
Reproductive and endocrine disorders
Gene-modified organism studies have revealed essential roles for proteolysis in reproduction, including gamete interaction and implantation. Hormone proteolysis generates bioactive fragments that regulate metabolism and endocrine function. Dysregulation of these processes can lead to reproductive and metabolic disorders.
From proteolysis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a protease required for ECM degradation? | CRISPR knockout in primary cells or organoids |
| Does a point mutation alter substrate specificity? | CRISPR point mutation knock-in |
| Where does a protease localize in cells? | Tagged knock-in with fluorescent protein |
| Does overexpression drive invasion? | CRISPR overexpression in cancer cell lines |
| Which genes regulate proteolysis? | CRISPR library screening |
| What are the downstream cleavage products? | Proteomics and bioinformatics analysis |
How to Study the proteolysis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry proteomics | Cleavage products and substrate identification | Degradomics of ECM and proteoglycans |
| CRISPR library screening | Genes regulating proteolysis | Cancer target discovery |
| FRET reporters | Real-time protease activity | Live-cell imaging of proteolysis |
| Western blot | Protein cleavage and abundance | Validation of knockout/overexpression |
| Immunohistochemistry | Protease localization in tissues | Disc degeneration and cancer |
| RNA-seq | Transcriptional changes in proteolysis genes | Pathway analysis |
| Bioinformatics | Network and pathway integration | Target prioritization |
Proteomics and degradomics
Mass spectrometry-based proteomics can identify cleavage products and map protease substrates. Degradomics approaches, such as terminal amine isotopic labeling of substrates (TAILS), enable global analysis of proteolysis. These methods are essential for understanding proteoglycan and ECM proteolysis.
CRISPR screening and functional genomics
CRISPR library screening can identify genes that regulate proteolysis, including proteases, inhibitors, and E3 ligases. Pooled screens with readouts such as protein degradation or invasion can uncover novel therapeutic targets.
Imaging and reporter assays
Fluorescent reporters and FRET-based sensors can visualize proteolysis in live cells. Tagged knock-in models allow tracking of protease localization and activity. These methods are useful for studying hormone proteolysis and ECM remodeling.
Bioinformatics and pathway analysis
Bioinformatics tools integrate proteomics, transcriptomics, and CRISPR screening data to identify proteolysis networks. Pathway enrichment analysis can reveal interactions between proteases and signaling pathways.
How CRISPR Can Be Used to Study GO:0006508 proteolysis
Knockout
CRISPR knockout of protease genes (e.g., MMP9, ADAMTS5) can determine their requirement for ECM degradation and disease progression. Knockout of E3 ligase components (e.g., CRBN) can reveal mechanisms of PROTAC resistance.
Point Mutation
Point mutations in catalytic domains of proteases can dissect substrate specificity and enzymatic activity. For example, mutating the catalytic triad of MMPs can abolish proteolysis while preserving substrate binding.
Knock-in
Knock-in of tagged proteases (e.g., GFP or HA) enables localization and interaction studies. Knock-in of patient mutations in PCSK1 can model endocrine disorders.
Overexpression
Overexpression of proteases such as MMP9 or CTSL can drive invasion and metastasis in cancer models. Overexpression of PROTAC components can enhance targeted protein degradation.
How EDITGENE Supports proteolysis Research
Researchers studying proteolysis-related genes often need to determine whether a candidate gene is causally involved in substrate cleavage, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for proteolysis research.
Frequently Asked Questions About proteolysis
What is GO:0006508 proteolysis?
GO:0006508 proteolysis is the biological process of hydrolyzing proteins into smaller polypeptides or amino acids by cleavage of peptide bonds.
What genes are involved in proteolysis?
Key genes include MMPs, ADAMTS proteases, cathepsins, proteasome subunits, and E3 ligases such as CRBN and VHL.
How is proteolysis regulated?
Proteolysis is regulated by protease expression, zymogen activation, inhibitors, compartmentalization, and the ubiquitin-proteasome system.
What diseases are linked to proteolysis?
Cancer, intervertebral disc degeneration, reproductive disorders, and endocrine imbalances are linked to dysregulated proteolysis.
What are PROTACs and how do they relate to proteolysis?
PROTACs are chimeric molecules that hijack the ubiquitin-proteasome system to degrade target proteins, exploiting proteolysis for therapy.
How can CRISPR be used to study proteolysis?
CRISPR knockout, point mutation, knock-in, and overexpression models can dissect the causal roles of proteolysis-related genes.
What methods are used to study proteolysis?
Proteomics, degradomics, CRISPR screening, imaging, and bioinformatics are commonly used.
Why is proteolysis important in the tumor microenvironment?
Acidosis promotes proteolysis, which degrades ECM and enhances invasion and metastasis.
What is the role of proteolysis in reproduction?
Gene-modified organism studies show proteolysis is essential for gamete interaction, implantation, and development.
How does hormone proteolysis work?
Specific proteases cleave hormone precursors to generate bioactive fragments with distinct endocrine functions.
Conclusion
GO:0006508 proteolysis is a central biological process that regulates protein turnover, ECM remodeling, hormone processing, and disease progression. Its therapeutic potential is exemplified by PROTACs and nano-PROTACs, which redirect proteolysis to degrade disease-causing proteins. Understanding the genes and mechanisms of proteolysis requires robust experimental models, and CRISPR-based approaches offer precise tools for causal discovery.
References
- 1. Kiyozumi D et al.. 2022. Proteolysis in Reproduction: Lessons From Gene-Modified Organism Studies.. Front Endocrinol (Lausanne) 13:876370 PMID: 35600599
- 2. Mead TJ et al.. 2022. Proteolysis: a key post-translational modification regulating proteoglycans.. Am J Physiol Cell Physiol 323(3):C651-C665 PMID: 35785985
- 3. Jin Y et al.. 2024. Proteolysis Targeting Chimeras (PROTACs) in Breast Cancer Therapy.. ChemMedChem 19(23):e202400267 PMID: 39136599
- 4. Song Y et al.. 2024. Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy.. Int J Nanomedicine 19:5739-5761 PMID: 38882545
- 5. Moreau K et al.. 2020. Proteolysis-targeting chimeras in drug development: A safety perspective.. Br J Pharmacol 177(8):1709-1718 PMID: 32022252
- 6. Liang H et al.. 2022. The Proteolysis of ECM in Intervertebral Disc Degeneration.. Int J Mol Sci 23(3) PMID: 35163637
- 7. Ji K et al.. 2019. Acidosis and proteolysis in the tumor microenvironment.. Cancer Metastasis Rev 38(1-2):103-112 PMID: 31069574
- 8. Triebel J et al.. 2022. New horizons in specific hormone proteolysis.. Trends Endocrinol Metab 33(6):371-377 PMID: 35397984
